Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphoma by Yoshito Nishimura, Yiqun Han, Nadia Toumeh, Guneet Janda, Yu Fujiwara, Urshila Durani, Grzegorz S. Nowakowski, Jonas Paludo, Stephen M. Ansell, Jithma P. Abeykoon

Get full text

Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience by Steven R. Hwang, Richard C. Godby, Brianna J. Negaard, Raphael Mwangi, Adrienne N. Nedved, Jason N. Barreto, Ivana N. Micallef, Stephen M. Ansell, Luis Porrata, Urshila Durani, Gita Thanarajasingam, Thomas M. Habermann, Matthew J. Maurer, Patrick B. Johnston, Arushi Khurana

Get full text

Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium by Jonathan R. Day, Melissa C. Larson, Urshila Durani, Jean L. Koff, Yucai Wang, Thomas M. Habermann, Izidore S. Lossos, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B. Cohen, Brad S. Kahl, Jia Ruan, W. Richard Burack, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer, Carla Casulo

Get full text

Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival by Jennifer J. Gile, Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal, Sangeetha Gandhi, Henan Zhang, Elham Babadi, Kodi Martinez, Gabrielle McCoy, Zuoyi Shao, Kevin Regan, Matthew A. Hathcock, Panwen Wang, Junwen Wang, Abdullah S. Al Saleh, Gordon Ruan, Stephen M. Ansell, N. Nora Bennani, Patrick B. Johnston, Jonas Paludo, Jose C. Villasboas-Bisneto, Arushi Khurana, Urshila Durani, Yucai Wang, Paul J. Hampel, Allison Rosenthal, Javier Munoz, Eider Moreno, Januario E. Castro, Hemant S. Murthy, Mohamed Kharfan-Dabaja, Saad S. Kenderian, Jenny J. Kim, Rhine Shen, Mike Mattie, Yi Lin, Thomas E. Witzig

Get full text